Skip to main content
. 2022 Jan 6;42(1):BSR20211783. doi: 10.1042/BSR20211783

Figure 10. HPA-based validation of MTHFD1L at translational level (×200).

Figure 10

(A) In bladder cancer, (B) in head and neck cancer, (C) in kidney cancer, (D) in lung cancer, and (E) in endometrial cancer.